GLO1 and diabetes mellitus: Glo-1 activity is decreased and MG-H1 residue content of proteins is increased in the kidney, retina and nerve of pre-clinical models of microvascular complications of diabetes (nephropathy, retinopathy and neuropathy) [79–83].